Rockefeller Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,500
Closed -$41K 3934
2022
Q3
$41K Hold
4,500
﹤0.01% 2451
2022
Q2
$21K Buy
+4,500
New +$21K ﹤0.01% 2717